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The hexane fraction of an Ardisia crispa ethanolic extract shows anti-arthritis effects in 
a rat arthritis model 
ABSTRACT 
Ardisia crispa has been claimed by local villagers to have medicinal properties, and it is 
widely used in treating dysmenorrhea, rheumatism, orchitis, skin problem, coughs, fractured 
bones, sprains and treatment for women afterbirth [1]. To date, there is no report documented 
on Ardisia crispa's effect on chronic inflammation especially on anti-arthritic properties. The 
hexane fraction of an ethanolic extract of Ardisia crispa root (ACHE) was used in this study. 
Complete Freund's adjuvant (CFA) was injected onto plantar aponeurosis of right paw of rat 
to induce chronic arthritis. The following day onwards, ACHE at 3, 10, 30, and 100mg/kg 
and also indomethacin as positive control were administered to the rats. Paw volume of rat 
was measured with a plethysmometer for 14 days. Ankle tissue was collected for ELISA test 
of tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β). The result show that 
ACHE at all doses (3.10.30 and 100mg/kg) have significant (p&lt;0.05) inhibition of oedema 
by 45.3%, 64.31%, 73.12% and 49.55% respectively. At 3, 10 and 30mg/kg, ACHE 
significantly reduced TNF-α by 45.2%, 45.7% and 25.1% respectively when compared with 
control. For IL-1β, only 10mg/kg and 30mg/kg of ACHE elicited a significant (p&lt;0.05) 
inhibition of this mediator in local tissue by 45.9% and 36.5% respectively. The efficacies of 
those doses were comparable to the effect of indomethacin (34.6%). Thus, it can be 
concluded that Ardisia crispa posseses anti-arthritic effect on specific FCA-induced arthritis 
model in rats.  
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